Logo image of LION

LIONSGATE STUDIOS CORP (LION) Stock Fundamental Analysis

NYSE:LION - New York Stock Exchange, Inc. - CA53626M1041 - Common Stock - Currency: USD

7.22  -0.57 (-7.32%)

After market: 7.22 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LION. LION was compared to 72 industry peers in the Entertainment industry. LION has a bad profitability rating. Also its financial health evaluation is rather negative. LION has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LION had negative earnings in the past year.
LION had a negative operating cash flow in the past year.
LION Yearly Net Income VS EBIT VS OCF VS FCFLION Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.70%, LION is in line with its industry, outperforming 56.94% of the companies in the same industry.
LION has a better Return On Invested Capital (4.15%) than 72.22% of its industry peers.
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROIC 4.15%
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LION Yearly ROA, ROE, ROICLION Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

LION's Operating Margin of 5.41% is fine compared to the rest of the industry. LION outperforms 70.83% of its industry peers.
LION has a better Gross Margin (117.71%) than 100.00% of its industry peers.
Industry RankSector Rank
OM 5.41%
PM (TTM) N/A
GM 117.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LION Yearly Profit, Operating, Gross MarginsLION Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, LION has about the same amount of shares outstanding.
There is no outstanding debt for LION. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LION Yearly Shares OutstandingLION Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
LION Yearly Total Debt VS Total AssetsLION Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LION has an Altman-Z score of -0.16. This is a bad value and indicates that LION is not financially healthy and even has some risk of bankruptcy.
LION has a worse Altman-Z score (-0.16) than 65.28% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.16
ROIC/WACCN/A
WACCN/A
LION Yearly LT Debt VS Equity VS FCFLION Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.36 indicates that LION may have some problems paying its short term obligations.
The Current ratio of LION (0.36) is worse than 80.56% of its industry peers.
LION has a Quick Ratio of 0.36. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
LION's Quick ratio of 0.36 is on the low side compared to the rest of the industry. LION is outperformed by 80.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
LION Yearly Current Assets VS Current LiabilitesLION Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

0

3. Growth

3.1 Past

LION shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -591.59%.
EPS 1Y (TTM)-591.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LION is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.84% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-107.73%
EPS Next 2Y90.5%
EPS Next 3Y3.84%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LION Yearly Revenue VS EstimatesLION Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 1B 2B 3B
LION Yearly EPS VS EstimatesLION Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.2 0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

LION reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 11.17, which indicates a very decent valuation of LION.
Based on the Price/Forward Earnings ratio, LION is valued cheaper than 94.44% of the companies in the same industry.
LION is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 11.17
LION Price Earnings VS Forward Price EarningsLION Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

LION's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LION is cheaper than 86.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.01
LION Per share dataLION EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.5%
EPS Next 3Y3.84%

0

5. Dividend

5.1 Amount

LION does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIONSGATE STUDIOS CORP

NYSE:LION (5/9/2025, 8:05:38 PM)

After market: 7.22 0 (0%)

7.22

-0.57 (-7.32%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)05-20 2025-05-20
Inst Owners10.48%
Inst Owner Change0.22%
Ins OwnersN/A
Ins Owner Change0%
Market Cap2.08B
Analysts84.44
Price Target12.41 (71.88%)
Short Float %12.57%
Short Ratio16.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)303.17%
Min EPS beat(2)-20.6%
Max EPS beat(2)626.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.44%
Max Revenue beat(2)3.22%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.87%
PT rev (3m)17.74%
EPS NQ rev (1m)0.83%
EPS NQ rev (3m)-5.51%
EPS NY rev (1m)-119.01%
EPS NY rev (3m)73.53%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-1.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.17
P/S 0.98
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 4.01
EPS(TTM)-0.47
EYN/A
EPS(NY)0.65
Fwd EY8.95%
FCF(TTM)-1.29
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS7.36
BVpS-3.74
TBVpS-15.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROCE 5.25%
ROIC 4.15%
ROICexc 4.53%
ROICexgc N/A
OM 5.41%
PM (TTM) N/A
GM 117.71%
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 1.48
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -0.16
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)0.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-591.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120.16%
EPS Next Y-107.73%
EPS Next 2Y90.5%
EPS Next 3Y3.84%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y331.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1422.04%
EBIT Next 3Y163.74%
EBIT Next 5YN/A
FCF growth 1Y-72843.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70899.5%
OCF growth 3YN/A
OCF growth 5YN/A